New Tiaoxin Recipe Alleviates Energy Metabolism Disorders in an APPswe/PS1DE9 Mouse Model of Alzheimer's Disease

被引:0
|
作者
Hu, Yiran [1 ]
Xing, Sanli [2 ]
Huang, Yan [2 ]
Chen, Chuan [2 ]
Shen, Dingzhu [2 ]
Chen, Jiulin [2 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shanghai 200031, Peoples R China
[2] Shanghai Geriatr Inst Chinese Med, Shanghai 200031, Peoples R China
关键词
Alzheimer's disease; energy dysmetabolism; new tiaoxin recipe; NAD plus; CD38; neurodegenerative disease; QUANTUM SPEEDUP;
D O I
10.2174/1386207326666230428112358
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Alzheimer's disease (AD) is a typical neurodegenerative disease with a complex etiology. Until now, there has been no effective treatment available for AD; however, improving energy dysmetabolism, the key pathological event in the early stage of AD, can effectively delay the progression of AD.Objective: This paper aims to investigate the therapeutic effect and potential mechanism of the new Tiaoxin recipe on early AD.Methods: APP/PS1 mice were divided into a model group, a new Tiaoxin recipe group, and a donepezil group, and C57/BL mice were used for the control group. Mouse cognitive and learning abilities were tested using the Morris water maze test and a new object-recognition experiment. The 42 amino acid form of amyloid beta peptide (A beta 1-42) content was detected by enzyme-linked immunosorbent assay, the senile plaque area was detected by thioflavin S staining, and the senescence-associated beta-galactosidase (SA-beta-gal)-positive area was detected by chemical staining. Also, the adenosine triphosphate (ATP), nicotinamide adenine dinucleotide (NAD+), and nicotinamide adenine dinucleotide hydride (NADH) contents were detected using a biochemical method, and the cluster of differentiation 38 (CD38) and silent mating-type information regulation 2 homolog 3 (SIRT3) protein expression levels were detected by immunofluorescence and Western blot analysis.Results: Compared with those of the control group, the learning and memory abilities of the model group were impaired; the senile plaque deposition, A beta 1-42 content, and SA-beta gal-positive staining area were increased; the ATP concentration, NAD+ concentration, and NAD+/NADH ratio were decreased; the CD38 protein expression level was increased; and the SIRT3 protein expression level was decreased. Following intervention with the new Tiaoxin recipe, the learning and memory abilities were improved; the senile plaque deposition, A beta 1-42 content, and SA-beta gal-positive area were reduced; the ATP concentration, NAD+ concentration, and NAD+/NADH ratio were increased; CD38 protein expression was decreased, and SIRT3 protein expression was increased.Conclusion: This study shows that the new Tiaoxin Recipe can improve cognitive ability and reduce the A beta 1-42 content and senile plaque deposition in APP/PS1 mice, which may occur through the downregulation of CD38 protein expression, upregulation of SIRT3 protein expression, restoration of the NAD+ level, promotion of ATP synthesis, mitigation of energy metabolism disorders.
引用
收藏
页码:621 / 631
页数:11
相关论文
共 50 条
  • [41] Mitochondrial dynamics changes with age in an APPsw/PS1dE9 mouse model of Alzheimer's disease
    Xu, Lin-Lin
    Shen, Yang
    Wang, Xiao
    Wei, Li-Fei
    Wang, Ping
    Yang, Hui
    Wang, Cun-Fu
    Xie, Zhao-Hong
    Bi, Jian-Zhong
    NEUROREPORT, 2017, 28 (04) : 222 - 228
  • [42] Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease:: Relationships to β-amyloid deposition and neurotransmitter abnormalities
    Savonenko, A
    Xu, GM
    Melnikova, T
    Morton, JL
    Gonzales, V
    Wong, MPF
    Price, DL
    Tang, F
    Markowska, AL
    Borchelt, DR
    NEUROBIOLOGY OF DISEASE, 2005, 18 (03) : 602 - 617
  • [43] Deficits in object-in-place but not relative recency performance in the APPswe/PS1dE9 mouse model of Alzheimer's disease: Implications for object recognition
    Bonardi, Charlotte
    Pardon, Marie-Christine
    Armstrong, Paul
    BEHAVIOURAL BRAIN RESEARCH, 2016, 313 : 71 - 81
  • [44] Terahertz Irradiation Improves Cognitive Impairments and Attenuates Alzheimer's Neuropathology in the APPSWE/PS1DE9 Mouse: A Novel Therapeutic Intervention for Alzheimer's Disease
    Zhang, Jun
    Chen, Yixin
    Zhao, Yarui
    Wang, Panpan
    Ding, Hongbin
    Liu, Cong
    Lyu, Junhong
    Le, Weidong
    NEUROSCIENCE BULLETIN, 2024, 40 (07) : 857 - 871
  • [45] The Protective Effect of Vanadium on Cognitive Impairment and the Neuropathology of Alzheimer's Disease in APPSwe/PS1dE9 Mice
    He, Zhijun
    Han, Shuangxue
    Zhu, Huazhang
    Hu, Xia
    Li, Xiaoqian
    Hou, Chaofan
    Wu, Chong
    Xie, Qingguo
    Li, Nan
    Du, Xiubo
    Ni, Jiazuan
    Liu, Qiong
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2020, 13
  • [46] Longitudinal assessment of cognitive function in the APPswe/PS1dE9 mouse model of Alzheimer's-related beta-amyloidosis
    Soto, Paul L.
    Young, Michael E.
    DiMarco, Giuliana M.
    George, Brianna
    Melnikova, Tatiana
    Savonenko, Alena, V
    Harris, Breanna N.
    NEUROBIOLOGY OF AGING, 2023, 128 : 85 - 99
  • [47] nAChRs gene expression and neuroinflammation in APPswe/PS1dE9 transgenic mouse
    Chiara, D'Angelo
    Erica, Costantini
    Nieves, Salvador
    Michele, Marchioni
    Marta, Di Nicola
    Nigel, Greig H.
    Marcella, Reale
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [48] CHANGES IN THE BRAIN AND PLASMA Ab PEPTIDE LEVELS WITH AGE AND ITS RELATIONSHIP WITH COGNITIVE IMPAIRMENT IN THE APPswe/PS1dE9 MOUSE MODEL OF ALZHEIMER'S DISEASE
    Izco, M.
    Martinez, P.
    Corrales, A.
    Fandos, N.
    Garcia, S.
    Insua, D.
    Montanes, M.
    Perez-Grijalba, V.
    Rueda, N.
    Vidal, V.
    Martinez-Cue, C.
    Pesini, P.
    Sarasa, M.
    NEUROSCIENCE, 2014, 263 : 269 - 279
  • [49] Gender differences in appswe/ps1de9 mice model of Alzheimer's disease in response to LPS-induced immune challenge
    Agostini, Alessandra
    Parhizkar, Samira
    Knapp, Stacey
    Ebling, Francis
    Pardon, Marie-Christine
    EXPERIMENTAL GERONTOLOGY, 2015, 68 : 98 - 99
  • [50] CHRONIC ADMINISTRATION OF MDMA IN APPSWE/PS1DE9 TRANSGENIC MICE DOES NOT EXACERBATE ALZHEIMER'S DISEASE IN ADULTHOOD
    Abad, S.
    Ramon, C.
    Camarasa, J.
    Pubill, D.
    Camins, A.
    Escubedo, E.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 182 - 182